Type 1 diabetes (T1D) is one of the major autoimmune diseases affecting children and young adults worldwide. To date, the different immunotherapies tested have achieved insulin independence in <5% of treated individuals. Recently, a novel hematopoietic stem cell (HSC)-based strategy has been tested in individuals with new-onset T1D. The aim of this study was to determine the effects of autologous nonmyeloablative HSC transplantation in 65 individuals with new-onset T1D who were enrolled in two Chinese centers and one Polish center, pooled, and followed up for 48 months. A total of 59% of individuals with T1D achieved insulin independence within the first 6 months after receiving conditioning immunosuppression therapy (with antithymocyte globulin and cyclophosphamide) and a single infusion of autologous HSCs, and 32% remained insulin independent at the last time point of their follow-up. All treated subjects showed a decrease in HbA1c levels and an increase in C-peptide levels compared with pretreatment. Despite a complete immune system recovery (i.e., leukocyte count) after treatment, 52% of treated individuals experienced adverse effects. Our study suggests the following: 1) that remission of T1D is possible by combining HSC transplantation and immunosuppression; 2) that autologous nonmyeloablative HSC transplantation represents an effective treatment for selected individuals with T1D; and 3) that safer HSC-based therapeutic options are required.
Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes : a multicenter analysis / F. D'Addio, A.V. Vasquez, M.B. Nasr, E. Franek, D. Zhu, L. Li, G. Ning, E. Snarski, P. Fiorina, M. Ben Nasr. - In: DIABETES. - ISSN 0012-1797. - 63:9(2014), pp. 3041-3046.
|Titolo:||Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes : a multicenter analysis|
D'ADDIO, FRANCESCA (Primo)
|Parole Chiave:||Adolescent; Adult; C-Peptide; Child; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppression; Insulin; Male; Remission Induction; Transplantation, Autologous; Hematopoietic Stem Cell Transplantation; Internal Medicine; Endocrinology, Diabetes and Metabolism|
|Settore Scientifico Disciplinare:||Settore MED/13 - Endocrinologia|
|Data di pubblicazione:||2014|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.2337/db14-0295|
|Appare nelle tipologie:||01 - Articolo su periodico|